Form SCHEDULE 13D/A Kezar Life Sciences, Filed by: TANG CAPITAL MANAGEMENT LLC May 13, 2026 04:15PM
Form SCHEDULE 13D/A Kezar Life Sciences, Filed by: TANG CAPITAL MANAGEMENT LLC Apr 1, 2026 04:15PM
Aurinia to acquire Kezar Life Sciences for $6.955 per share plus CVR Mar 30, 2026 08:01AM
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right Mar 30, 2026 08:00AM
H.C. Wainwright Reiterates Neutral Rating on Kezer Life Sciences (KZR) Oct 14, 2024 07:23AM


Oct 10, 2024 08:32AM Kezar Life Sciences (KZR) Confirms Receipt of Unsolicited, Non-Binding Acquisition Proposal
Oct 10, 2024 08:30AM Kezar Confirms Receipt of Unsolicited, Non-Binding Acquisition Proposal
Oct 8, 2024 04:27PM Kezar Life Sciences (KZR) Shareholder Kevin Tang Offers to Acquire 100% of Company for $1.10 Per Share Plus CVR
Oct 8, 2024 04:20PM Form SC 13D Kezar Life Sciences, Filed by: TANG CAPITAL MANAGEMENT LLC